{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.09","value":"1.93"},{"groupId":"OG001","spread":"0.08","value":"2.01"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"64"}],"units":"Participants"}],"description":"The Wisconsin Smoking Withdrawal Scale is a 28 item questionnaire that assesses nicotine withdrawal. It consists of seven subscales, each consisting of 3-5 questions all answered on a 0-4 scale. Subscale scores are the mean of the items comprising the scale. Some items are reverse scored. Higher scores indicate greater withdrawal symptoms. Subscales were scored if more than half the items were answered. A total score was calculated as the mean of the individual subscales (if more than half the subscales had scores).","dispersionType":"Standard Error","groups":[{"description":"Participants receive memantine hydrochloride PO BID) on days 1-81 in the absence of unacceptable toxicity.\n\nmemantine hydrochloride: Estimate participation, accrual, adherence, and retention of cancer survivors who smoke and are randomized to receive memantine (10 mg twice daily) or a matching placebo for 12 weeks.","id":"OG000","title":"Arm I - Memantine"},{"description":"Participants receive a placebo PO BID on days 1-81 in the absence of unacceptable toxicity.\n\nplacebo: Placebo by mouth through completion of 12 weeks.","id":"OG001","title":"Arm II - Placebo"}],"paramType":"LEAST_SQUARES_MEAN","populationDescription":"Participants who provided data at any time","reportingStatus":"POSTED","timeFrame":"12 weeks","title":"Smoking Withdrawal","type":"SECONDARY","unitOfMeasure":"units on a scale"}